Lanean...
Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy
High tumor mutational burden (TMB) is associated with response to checkpoint blockade in several cancers. We identify pathogenic germline variants associated with increased TMB (GVITMB). GVITMB were found in 7 genes using a pan-cancer approach (APC, FANCL, SLC25A13, ERCC3, MSH6, PMS2, and TP53) and...
Gorde:
| Argitaratua izan da: | iScience |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988326/ https://ncbi.nlm.nih.gov/pubmed/33786423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2021.102248 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|